Bruce Johnson
Dana-Farber Cancer Insitute

Last Updated On 3/20/2024 8:13:27 AM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Checkpoint Therapeutics
Recipient: You
Company: Jazz Pharmaceuticals
Recipient: You
Company: Genentech
Recipient: You
Company: Astra Zeneca
Recipient: You
Company: Bluedot Bio
Recipient: You
Company: Merus NV
Recipient: You
Company: Abdera
Recipient: You
Company: Simcere Pharmaceutical Company
Recipient: You
Company: Janssen Global Services,
Recipient: You
Company: Revolution Medicines
Recipient: You
Company: Redona Therapeutics.
Recipient: You
Company: Pfizer/Array
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
No Relationships to Disclose

Patents, Royalties, Other Intellectual Property
Please describe: Dana-Farber Cancer Institute
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
not answered